The FDA is reviewing Edwards Lifesciences' request to extend by 1,757 days the patent covering the company's Sapien transcatheter aortic valve implant, which was approved by the agency in November 2011. The agency will accept public comments on the patent extension request through April 23.
Edwards asks FDA to extend patent for Sapien heart valve
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||